SA
Log In
NHI
OverviewIntelligenceChart

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
17 analysts·Moderate coverage
29%
Rating Distribution
Strong Buy
00%
Buy
529%
Hold
1165%
Sell
16%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 0% above analyst consensus — near fair value expected.

Bear Case
$83.00
-3%
Consensus
$85.40
-0%
Bull Case
$88.00
+3%
Price Range17 analysts
Low
Consensus
High
$83.00
$88.00
Current Target
Current Price
$85.65
Above Target
$0.25

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+15.19%
EPS+7.75%
FY2028
Rev-6.71%
EPS+2.18%
FY2029
Rev+0.74%
EPS—

Earnings Surprises

Recent Analyst Actions

Mar 27, 2026Wells Fargo
National Health Investors price target raised to $86 from $85 at Wells Fargo
Target:$86.00
+4.6%from $82.20
Jan 20, 2026National Bank
National Health Investors downgraded to Hold from Buy at Deutsche Bank
Target:$85.00
+6.0%from $80.17
Jan 5, 2026Cantor Fitzgerald
National Health Investors price target lowered to $85 from $87 at Cantor Fitzgerald
Target:$85.00
+10.6%from $76.85
Dec 15, 2025Truist Financial
National Health Investors (NHI) PT Raised to $83 at Truist Securities
Target:$83.00
+6.4%from $78.03
Dec 4, 2025KeyBanc
National Health Investors price target raised to $88 from $80 at KeyBanc
Target:$88.00
+11.6%from $78.85
Nov 25, 2025Wells Fargo
National Health Investors price target raised to $85 from $80 at Wells Fargo
Target:$85.00
+7.0%from $79.47
Oct 1, 2025National Bank
National Health Investors initiated with an Overweight at Cantor Fitzgerald
Target:$90.00
+13.2%from $79.50
Jul 2, 2025Truist Financial
National Health Investors upgraded to Buy from Hold at Truist
Target:$77.00
+9.2%from $70.52
Sep 24, 2024Bank of America Securities
BofA Securities Starts National Health Investors (NHI) at Buy
Target:$92.00
+8.6%from $84.71
Aug 30, 2024Truist Financial
National Health Investors price target raised to $78 from $65 at Truist
Target:$78.00
-3.4%from $80.74
Apr 3, 2024Truist Financial
National Health Investors (NHI) PT Raised to $58 at Truist Securities
Target:$58.00
-3.2%from $59.89
Mar 12, 2024National Bank
BMO Capital Upgrades National Health Investors (NHI) to Outperform, 'Turning the Corner & Finally Hitting Its Stride'
Target:$67.00
+12.5%from $59.56
Feb 26, 2024Wells Fargo
Wells Fargo Upgrades National Health Investors (NHI) to Overweight
Target:$63.00
+9.1%from $57.76
Dec 9, 2022National Bank
National Health upgraded to Neutral from Underperform at Credit Suisse
Target:$58.00
+2.6%from $56.54
Sep 26, 2022Truist Financial
Truist Securities Maintains Hold on National Health Investors, Lowers Price Target to $61
Target:$61.00
+10.0%from $55.44
Apr 18, 2022BMO Capital
National Health Investors price target lowered to $61 from $63 at BMO Capital
Target:$61.00
+11.7%from $54.59

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance